company background image
UNVO logo

Univo Pharmaceuticals TASE:UNVO Stock Report

Last Price

₪0.093

Market Cap

₪2.8m

7D

0%

1Y

-94.3%

Updated

14 Mar, 2023

Data

Company Financials

Univo Pharmaceuticals Ltd

TASE:UNVO Stock Report

Market Cap: ₪2.8m

UNVO Stock Overview

Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products.

UNVO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Univo Pharmaceuticals Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Univo Pharmaceuticals
Historical stock prices
Current Share Price₪0.093
52 Week High₪1.76
52 Week Low₪0.09
Beta0.78
1 Month Change0%
3 Month Change-7.00%
1 Year Change-94.34%
3 Year Change-94.56%
5 Year Changen/a
Change since IPO-97.99%

Recent News & Updates

Is Univo Pharmaceuticals (TLV:UNVO) A Risky Investment?

Jan 26
Is Univo Pharmaceuticals (TLV:UNVO) A Risky Investment?

Recent updates

Is Univo Pharmaceuticals (TLV:UNVO) A Risky Investment?

Jan 26
Is Univo Pharmaceuticals (TLV:UNVO) A Risky Investment?

Shareholder Returns

UNVOIL BiotechsIL Market
7D0%3.8%3.0%
1Y-94.3%30.3%12.1%

Return vs Industry: UNVO underperformed the IL Biotechs industry which returned 18.8% over the past year.

Return vs Market: UNVO underperformed the IL Market which returned -8.8% over the past year.

Price Volatility

Is UNVO's price volatile compared to industry and market?
UNVO volatility
UNVO Average Weekly Movementn/a
Biotechs Industry Average Movement7.1%
Market Average Movement4.3%
10% most volatile stocks in IL Market8.4%
10% least volatile stocks in IL Market3.0%

Stable Share Price: UNVO's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine UNVO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199376Golan Bittonhttps://www.unv-medicine.com

Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products. The company was formerly known as Di-Pharm Ltd and changed its name to Univo Pharmaceuticals Ltd in September 2018. Univo Pharmaceuticals Ltd was incorporated in 1993 and is based in Ashkelon, Israel.

Univo Pharmaceuticals Ltd Fundamentals Summary

How do Univo Pharmaceuticals's earnings and revenue compare to its market cap?
UNVO fundamental statistics
Market cap₪2.84m
Earnings (TTM)-₪32.19m
Revenue (TTM)₪43.89m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UNVO income statement (TTM)
Revenue₪43.89m
Cost of Revenue₪43.25m
Gross Profit₪639.00k
Other Expenses₪32.83m
Earnings-₪32.19m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin1.46%
Net Profit Margin-73.35%
Debt/Equity Ratio193.1%

How did UNVO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.